Search hospitals > Hawaii > Honolulu
Island Urology
Claim this profileHonolulu, Hawaii 96813
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
96 reported clinical trials
5 medical researchers
Summary
Island Urology is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Island Urology is involved with conducting 96 clinical trials across 243 conditions. There are 5 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Kenneth N. Sumida, and Craig S. Boddy.Area of expertise
1Lung Cancer
Global LeaderStage II
Stage I
Stage IV
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
Top PIs
Jeffrey L. BerenbergStraub Clinic and Hospital2 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
29 reported clinical trials
77 drugs studied
Jared D. AcobaQueen's Medical Center2 years of reported clinical research
Studies Colon Cancer
Studies Pancreatic Cancer
18 reported clinical trials
38 drugs studied
Kenneth N. SumidaQueen's Medical Center10 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
8 reported clinical trials
20 drugs studied
Craig S. BoddyHawaii Cancer Care - Savio6 years of reported clinical research
Studies Chronic Myeloid Leukemia
Studies Lymphoma
7 reported clinical trials
35 drugs studied
Clinical Trials running at Island Urology
Lung Cancer
Non-Small Cell Lung Cancer
Laryngeal Cancer
Breast cancer
Oropharyngeal Carcinoma
ALK Gene Rearrangement
Breast Cancer
Cardiotoxicity
Squamous Cell Carcinoma
Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Radiation + Immunotherapy
for Non-Small Cell Lung Cancer
This phase II trial studies the side effects of radiation therapy followed by atezolizumab in treating patients with stage II or III non-small cell lung cancer. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more cancer cells and have fewer side effects. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to test the safety and effectiveness of radiation therapy followed by atezolizumab and find out what side effects, if any, it has on patient's non-small cell lung cancer.
Recruiting1 award Phase 239 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Island Urology?
Island Urology is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Island Urology is involved with conducting 96 clinical trials across 243 conditions. There are 5 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Kenneth N. Sumida, and Craig S. Boddy.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.